"The decision is for now the most sweeping threat to abortion access since the supreme court rolled back abortion rights in 2022, said Kelly Baden, vice-president at the Guttmacher Institute."
"If allowed to stand, it would severely restrict access to mifepristone in every state, including those where abortion is broadly legal and where voters have acted to protect abortion rights."
"The ruling was hailed by Louisiana's Republican attorney general, Liz Murrill, who in a statement said she would look forward to continuing to defend women and babies as this case continues."
"A conservative three-judge panel of the fifth US circuit court of appeals in New Orleans agreed with Louisiana that the FDA had failed to justify eliminating the in-person dispensing requirement."
A US appeals court ruling has temporarily blocked the mail distribution of mifepristone, a medication used to end pregnancies. This decision poses a significant threat to abortion access, particularly in states where abortion rights are protected. Mifepristone is part of a two-drug regimen widely used in abortions and has seen increased usage since the 2022 Supreme Court ruling that overturned federal abortion protections. The ruling stems from a Louisiana lawsuit challenging the FDA's regulations on the drug's distribution.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]